Retour à l'accueil - Logo OERECA

EA 2608 | Oestrogènes, reproduction, cancer

Accueil > Publications et diffusion scientifique > Publications et diffusion scientifique


2014

Stallion spermatozoa: putative target of estrogens; presence of the estrogen receptors ESR1, ESR2 and identification of the estrogen-membrane receptor GPER.
Arkoun B, Gautier C, Delalande C, Barrier-Battut I, Guénon I, Goux D, Bouraïma-Lelong H.
Gen Comp Endocrinol. 2014 May 1;200:35-43. doi: 10.1016/j.ygcen.2014.02.016. Epub 2014 Mar 4.

No evidence for genetic association between glutamate transporter EAAT2 and Devic's neuromyelitis optica in caucasians and afro-caribbeans.
Hanoux V, Coulbault L, Derache N, Cabre P, De Seze J, Marignier R, Rudolf G, Emmanuelle Dugué A, Allouche S, Defer G; NOMADMUS Study Group.
Mult Scler Relat Disord. 2014 Jan;3(1):89-93. doi: 10.1016/j.msard.2013.06.012. Epub 2013 Jul 18.

Conclusiveness of toxicity data and double standards.
Séralini GE, Mesnage R, Defarge N, Spiroux de Vendômois J.
Food Chem Toxicol. 2014 Jul;69:357-9. doi: 10.1016/j.fct.2014.04.018. Epub 2014 Apr 18. No abstract available.

Conflicts of interests, confidentiality and censorship in health risk assessment: the example of an herbicide and a GMO.
Séralini GE, Mesnage R, Defarge N, Spiroux de Vendômois J.
Environ Sci Eur. 2014;26(1):13. Epub 2014 Jun 24.

Clinical Outcome, Hormonal Status, Gonadotrope Axis, and Testicular Function in 219 Adult Men Born With Classic 21-Hydroxylase Deficiency. A French National Survey.
Bouvattier C, Esterle L, Renoult-Pierre P, de la Perrière AB, Illouz F, Kerlan V, Pascal-Vigneron V, Drui D, Christin-Maitre S, Galland F, Brue T, Reznik Y, Schillo F, Pinsard D, Piguel X, Chabrier G, Decoudier B, Emy P, Tauveron I, Raffin-Sanson ML, Bertherat J, Kuhn JM, Caron P, Cartigny M, Chabre O, Dewailly D, Morel Y, Touraine P, Tardy-Guidollet V, Young J.
J Clin Endocrinol Metab. 2015 Jun;100(6):2303-13. doi: 10.1210/jc.2014-4124. Epub 2015 Mar 30.

Comment on Home et al. Insulin therapy in people with type 2 diabetes: opportunities and challenges? Diabetes care 2014;37:1499-1508.
Conget I, Aronson R, Lee S, Cohen O, Reznik Y.
Diabetes Care. 2014 Nov;37(11):e245-6. doi: 10.2337/dc14-1632. No abstract available.

Reductions in A1C with pump therapy in type 2 diabetes are independent of C-peptide and anti-glutamic acid decarboxylase antibody concentrations.
Reznik Y, Huang S; OpT2mise Study Group.
Diabetes Technol Ther. 2014 Nov;16(11):816-8. doi: 10.1089/dia.2014.0261. Epub 2014 Sep 5. No abstract available.

Neuromuscular electrostimulation and insulin sensitivity in patients with type 2 diabetes: the ELECTRODIAB pilot study.
Joubert M, Metayer L, Prevost G, Morera J, Rod A, Cailleux A, Parienti JJ, Reznik Y.
Acta Diabetol. 2015 Apr;52(2):285-91. doi: 10.1007/s00592-014-0636-5. Epub 2014 Aug 9.

Preliminary evaluation of a new semi-closed-loop insulin therapy system over the prandial period in adult patients with type 1 diabetes: the WP6.0 Diabeloop study.
Quemerais MA, Doron M, Dutrech F, Melki V, Franc S, Antonakios M, Charpentier G, Hanaire H, Benhamou PY; Diabeloop Consortium; Diabeloop Consortium.
J Diabetes Sci Technol. 2014 Nov;8(6):1177-84. doi: 10.1177/1932296814545668. Epub 2014 Aug 4.

Accuracy of a new patch pump based on a microelectromechanical system (MEMS) compared to other commercially available insulin pumps: results of the first in vitro and in vivo studies.
Borot S, Franc S, Cristante J, Penfornis A, Benhamou PY, Guerci B, Hanaire H, Renard E, Reznik Y, Simon C, Charpentier G; Diabeloop Study Group.
J Diabetes Sci Technol. 2014 Nov;8(6):1133-41. doi: 10.1177/1932296814543946. Epub 2014 Jul 30.

Abnormal Sensitivity to Glucagon and Related Peptides in Primary Adrenal Cushing's Syndrome.
Louiset E, Duparc C, Groussin L, Gobet F, Desailloud R, Barrande G, Reznik Y, Bertherat J, Prévost G, Lefebvre H.
Horm Metab Res. 2014 Nov;46(12):876-82. doi: 10.1055/s-0034-1384522. Epub 2014 Jul 23.

Insulin pump treatment compared with multiple daily injections for treatment of type 2 diabetes (OpT2mise): a randomised open-label controlled trial.
Reznik Y, Cohen O, Aronson R, Conget I, Runzis S, Castaneda J, Lee SW; OpT2mise Study Group.
Lancet. 2014 Oct 4;384(9950):1265-72. doi: 10.1016/S0140-6736(14)61037-0. Epub 2014 Jul 2.

Cross-sectional survey and retrospective analysis of a large cohort of adults with type 1 diabetes with long-term continuous subcutaneous insulin infusion treatment.
Joubert M, Morera J, Vicente A, Rod A, Parienti JJ, Reznik Y.
J Diabetes Sci Technol. 2014 Sep;8(5):1005-10. doi: 10.1177/1932296814537040. Epub 2014 May 27.

Autonomy of patients with type 2 diabetes with an insulin pump device: is it predictable?
Reznik Y, Morello R, Zenia A, Morera J, Rod A, Joubert M.
J Diabetes Sci Technol. 2014 Jul;8(4):760-5. doi: 10.1177/1932296814533171. Epub 2014 Apr 30.

[Malignant insulinoma: recommendations for workup and treatment].
Baudin E, Caron P, Lombard-Bohas C, Tabarin A, Mitry E, Reznick Y, Taieb D, Pattou F, Goudet P, Vezzosi D, Scoazec JY, Cadiot G, Borson-Chazot F, Do Cao C; pour la Société française d’endocrinologie et le Groupe d’étude des tumeurs endocrines.
Presse Med. 2014 Jun;43(6 Pt 1):645-59. doi: 10.1016/j.lpm.2013.08.007. Epub 2014 May 21. French.

OpT2mise: a randomized controlled trial to compare insulin pump therapy with multiple daily injections in the treatment of type 2 diabetes-research design and methods.
Aronson R, Cohen O, Conget I, Runzis S, Castaneda J, de Portu S, Lee S, Reznik Y; OpT2mise Study Group.
Diabetes Technol Ther. 2014 Jul;16(7):414-20. doi: 10.1089/dia.2013.0363. Epub 2014 Apr 15.

[Treatment of adrenal deficiency: To what issues? By which therapeutic means?].
Reznik Y.
Presse Med. 2014 Apr;43(4 Pt 1):438-43. doi: 10.1016/j.lpm.2014.02.003. Epub 2014 Mar 11. Review. French.

Patients lost to follow-up in acromegaly: results of the ACROSPECT study.
Delemer B, Chanson P, Foubert L, Borson-Chazot F, Chabre O, Tabarin A, Weryha G, Cortet-Rudelli C, Raingeard I, Reznik Y, Reines C, Bisot-Locard S, Castinetti F.
Eur J Endocrinol. 2014 Apr 19;170(5):791-7. doi: 10.1530/EJE-13-0924. Print 2014 May.

Treating diabetes with islet transplantation: lessons from the past decade in Lille.
Vantyghem MC, Defrance F, Quintin D, Leroy C, Raverdi V, Prévost G, Caiazzo R, Kerr-Conte J, Glowacki F, Hazzan M, Noel C, Pattou F, Diamenord AS, Bresson R, Bourdelle-Hego MF, Cazaubiel M, Cordonnier M, Delefosse D, Dorey F, Fayard A, Fermon C, Fontaine P, Gillot C, Haye S, Le Guillou AC, Karrouz W, Lemaire C, Lepeut M, Leroy R, Mycinski B, Parent E, Siame C, Sterkers A, Torres F, Verier-Mine O, Verlet E; G4 working groups, Desailloud R, Dürrbach A, Godin M, Lalau JD, Lukas-Croisier C, Thervet E, Toupance O, Reznik Y, Westeel PF.
Diabetes Metab. 2014 Apr;40(2):108-19. doi: 10.1016/j.diabet.2013.10.003. Epub 2014 Feb 6. Review.


Télécharger la page

Dernière modification : 24 juillet 2017



Université de Caen Normandie
Laboratoire OERECA
Esplanade de la Paix | CS 14032 | 14032 CAEN cedex 5